ADX10059
ADX10059-205
Phase 2 small_molecule completed
Quick answer
ADX10059 for Gastroesophageal Reflux is a Phase 2 program (small_molecule) at Addex Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Addex Therapeutics
- Indication
- Gastroesophageal Reflux
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed